$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of indications and applicable patients of ruxolitinib tablets
2026-02-01 22:25:32
Check Details
Where to buy clofazimine and how to get it
2026-02-01 22:25:32
Check Details
Does gosatuzumab (Todavi) have a high cure rate? How effective is it in patients with different conditions?
2026-02-01 22:25:32
Check Details
How many injections of evantumumab are needed in a year? How is the period and frequency of treatment determined?
2026-02-01 22:25:32
Check Details
What should I pay attention to when using Ivonib? What medications should be avoided before and after taking them?
2026-02-01 22:25:32
Check Details
What are the reactions after taking mitotane? Analysis of common side effects and countermeasures
2026-02-01 22:25:32
Check Details
Where to buy pemetinib, a cholangiocarcinoma targeting drug? Recommended formal drug purchasing channels at home and abroad
2026-02-01 22:25:32
Check Details
How long should I take erdafitinib? Standard course of treatment and effects of long-term use
2026-02-01 22:25:32
Check Details
What is the mechanism of action of margetuximab? In what ways does it exert its therapeutic effect?
2026-02-01 22:25:32
Check Details
Comparison of the price of Laos version of dacomitinib with other versions
2026-02-01 22:25:32
Check Details
What are the generic versions of brigatinib? What are the differences in effectiveness and price with the original drug?
2026-02-01 22:25:32
Check Details
How much does the Lao version of entrectinib cost? How much do other versions cost?
2026-02-01 22:25:32
Check Details
1
2
...
1376
1377
1378
1379
1380
1381
1382
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
2
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
3
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
4
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
5
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
6
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
7
User Agreement
8
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
9
What is the most important information I should know about WELIREG?
10
How to take and store WELIREG
11
How to take TRUSELTIQ correctly
12
How to deal with LONSURF side effects (1)